Anixa Biosciences, Inc.
ANIX
$3.38
-$0.17-4.79%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.65% | -16.19% | -27.96% | -16.65% | -7.04% |
| Total Depreciation and Amortization | -37.50% | -31.25% | -19.57% | -11.11% | 9.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.46% | -12.58% | 0.87% | 6.71% | 0.23% |
| Change in Net Operating Assets | 100.66% | 148.91% | 149.62% | -736.05% | -333.51% |
| Cash from Operations | -11.12% | -21.44% | -18.13% | -43.61% | -24.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,072.52% | 240.14% | 176.33% | 118.87% | 94.73% |
| Cash from Investing | 1,072.52% | 240.14% | 176.33% | 118.87% | 94.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.25% | 664.42% | 816.39% | 4,075.86% | 277.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -196.49% | -- | -- | -- |
| Cash from Financing | -92.56% | -56.78% | 833.06% | 1,308.08% | 550.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.78% | 100.63% | 103.11% | 90.63% | 79.08% |